Table 2.
Average cost per patient in each cohort
| Cost item | Average cost (USD) | Data source |
|---|---|---|
| Intervention | ||
| Outpatient cost | 8.31 | [11] |
| Inpatient cost | 0.9 | Health facilities |
| Motivational interviewing | 0.0032 | Health facilities |
| Economic incentives | 4.78a | Health facilities |
| CD4 Count test | 22.4 | Health facilities |
| Viral Load test | 133.3 | Health facilities |
| Transportation of samples to lab | 22.4 | Health facilities |
| Medication costs | 139.51 | [10] |
| Phone calls to track patients | 0.19 | Health facilities |
| Additional laboratory investigations | 6.91 | Health facilities |
| Total | 338.70 | |
| Control arm | ||
| Outpatient cost | 8.31 | [11] |
| Inpatient cost | 0.00 | Health facilities |
| CD4 Count test | 5.6 | Health facilities |
| Viral Load test | 33.3 | Health facilities |
| Transportation of samples to lab | 5.6 | Health facilities |
| Medication costs | 117.87 | [10] |
| Phone calls to track patients | 0.16 | Health facilities |
| Additional laboratory investigations | 1.84 | Health facilities |
| Total | 172.68 | |
a For patients who received the incentive, the average total amount received was US$16.84